| Withdrawn | A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Canc Breast Cancer, Triple Negative Breast Neoplasms, Triple-Negative Breast Neoplasm | Phase 2 | 2016-03-01 |
| Withdrawn | Phase 2 Trial of Durvalumab With or Without Bavituximab in Patients With Previously Treated Metastatic Non-sma Non-Small Cell Lung Cancer | Phase 2 | 2016-02-01 |
| Withdrawn | Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 / Phase 3 | 2015-12-01 |
| Completed | Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous No Non-Small-Cell Lung Cancer Stage IIIB, Non-Small-Cell Lung Cancer Stage IV, Non-Small-Cell Lung Cancer Metastatic | Phase 3 | 2013-12-01 |
| Terminated | Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors Malignant Solid Tumor | EARLY_Phase 1 | 2012-06-01 |
| Completed | Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Can Metastatic Pancreatic Cancer | Phase 2 | 2011-01-01 |
| Completed | Pilot Trial of Bavituximab Combined With Ribavirin for Initial Treatment of Chronic HepC Virus Genotype 1 Infe Hepatitis C | Phase 1 / Phase 2 | 2011-01-01 |
| Completed | Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer Non-Squamous Non-Small Cell Lung Cancer | Phase 2 | 2010-06-01 |
| Completed | Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cel Non-small-cell Lung Cancer | Phase 2 | 2010-06-01 |
| Completed | Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer Carcinoma Breast Stage IV | Phase 2 | 2008-07-01 |
| Completed | Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients With Non-Small Cell Lung Cancer Non-small Cell Lung Cancer | Phase 2 | 2008-06-01 |
| Completed | A Safety and Efficacy Study of Bavituximab Plus Docetaxel in Patients With Advanced Breast Cancer Breast Cancer | Phase 2 | 2008-01-01 |
| Completed | Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficienc Hepatitis C Virus, Hiv Infections | Phase 1 | 2007-07-01 |
| Completed | Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse Glioblastoma Multiforme | Phase 2 | 2007-07-01 |
| Completed | Safety & Radiation Distribution Study of Cotara® in Patients With Recurrent Glioblastoma Multiforme Recurrent Glioblastoma Multiforme | Phase 1 | 2006-11-01 |
| Completed | Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C Hepatitis C | Phase 1 | 2006-05-01 |
| Completed | Study of Bavituximab in Patients With Chronic Hepatitis C Virus Infection Hepatitis C | Phase 1 | 2005-08-01 |
| Completed | Study of Bavituximab in Patients With Advanced Solid Tumor Malignancies Tumors | Phase 1 | 2005-06-01 |
| Completed | Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma Brain and Central Nervous System Tumors | Phase 2 | 2000-02-01 |